Compare Pfizer with Dishman Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs DISHMAN PHARMA - Comparison Results

PFIZER     Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DISHMAN PHARMA 
   Change

Dishman Pharmaceuticals is involved in the manufacture of APIs (active pharmaceutical ingredients), intermediates, quaternary compounds and fine chemicals. Besides this, the company is a significant player in the CRAMS (Contract Research and Manufact... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER DISHMAN PHARMA PFIZER/
DISHMAN PHARMA
 
P/E (TTM) x 33.0 25.1 131.4% View Chart
P/BV x 5.5 3.3 165.2% View Chart
Dividend Yield % 0.6 0.7 92.8%  

Financials

 PFIZER   DISHMAN PHARMA
EQUITY SHARE DATA
    PFIZER
Mar-18
DISHMAN PHARMA
Mar-16
PFIZER/
DISHMAN PHARMA
5-Yr Chart
Click to enlarge
High Rs2,365374 631.7%   
Low Rs1,625129 1,260.7%   
Sales per share (Unadj.) Rs430.3197.8 217.5%  
Earnings per share (Unadj.) Rs78.721.2 371.1%  
Cash flow per share (Unadj.) Rs93.234.7 268.4%  
Dividends per share (Unadj.) Rs20.002.00 1,000.0%  
Dividend yield (eoy) %1.00.8 126.1%  
Book value per share (Unadj.) Rs586.5179.9 326.0%  
Shares outstanding (eoy) m45.7580.69 56.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.61.3 364.4%   
Avg P/E ratio x25.311.9 213.6%  
P/CF ratio (eoy) x21.47.2 295.4%  
Price / Book Value ratio x3.41.4 243.2%  
Dividend payout %25.49.4 269.4%   
Avg Mkt Cap Rs m91,27120,306 449.5%   
No. of employees `0002.60.8 317.2%   
Total wages/salary Rs m3,1435,355 58.7%   
Avg. sales/employee Rs Th7,484.819,252.7 38.9%   
Avg. wages/employee Rs Th1,195.06,459.5 18.5%   
Avg. net profit/employee Rs Th1,369.12,064.1 66.3%   
INCOME DATA
Net Sales Rs m19,68515,961 123.3%  
Other income Rs m1,143265 430.6%   
Total revenues Rs m20,82816,226 128.4%   
Gross profit Rs m5,0034,103 121.9%  
Depreciation Rs m6631,091 60.7%   
Interest Rs m4944 0.4%   
Profit before tax Rs m5,4792,334 234.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m01 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,878624 301.2%   
Profit after tax Rs m3,6011,711 210.4%  
Gross profit margin %25.425.7 98.9%  
Effective tax rate %34.326.7 128.3%   
Net profit margin %18.310.7 170.6%  
BALANCE SHEET DATA
Current assets Rs m24,16711,018 219.3%   
Current liabilities Rs m9,5449,517 100.3%   
Net working cap to sales %74.39.4 789.9%  
Current ratio x2.51.2 218.7%  
Inventory Days Days55110 49.9%  
Debtors Days Days2935 82.4%  
Net fixed assets Rs m9,51416,304 58.4%   
Share capital Rs m458161 283.5%   
"Free" reserves Rs m26,37512,907 204.3%   
Net worth Rs m26,83214,516 184.9%   
Long term debt Rs m254,189 0.6%   
Total assets Rs m36,90029,805 123.8%  
Interest coverage x1,305.53.5 37,613.2%   
Debt to equity ratio x00.3 0.3%  
Sales to assets ratio x0.50.5 99.6%   
Return on assets %9.88.9 109.7%  
Return on equity %13.411.8 113.8%  
Return on capital %20.417.5 116.5%  
Exports to sales %024.8 0.0%   
Imports to sales %03.7 0.0%   
Exports (fob) Rs mNA3,956 0.0%   
Imports (cif) Rs mNA596 0.0%   
Fx inflow Rs m224,952 0.5%   
Fx outflow Rs m1,489697 213.6%   
Net fx Rs m-1,4664,255 -34.5%   
CASH FLOW
From Operations Rs m3,3182,786 119.1%  
From Investments Rs m-2,383-1,529 155.9%  
From Financial Activity Rs m-1,104-941 117.3%  
Net Cashflow Rs m-169316 -53.3%  

Share Holding

Indian Promoters % 0.0 61.4 -  
Foreign collaborators % 63.9 0.0 -  
Indian inst/Mut Fund % 7.5 3.7 202.7%  
FIIs % 4.9 12.7 38.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.7 22.1 107.2%  
Shareholders   85,207 46,261 184.2%  
Pledged promoter(s) holding % 0.0 35.8 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   TORRENT PHARMA  ALKEM LABORATORIES  AJANTA PHARMA  SANOFI INDIA  ALEMBIC PHARMA  

Compare PFIZER With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Slumps 470 Points; Energy and Banking Stocks Witness Selling(Closing)

Indian share markets witnessed negative trading activity throughout the day and ended deep in the red. The BSE Sensex fell over 550 points intraday and breached the 36,000 mark.

Related Views on News

PFIZER Announces Quarterly Results (1QFY20); Net Profit Up 22.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, PFIZER has posted a net profit of Rs 1 bn (up 22.8% YoY). Sales on the other hand came in at Rs 5 bn (up 6.3% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (4QFY19); Net Profit Up 4.7% (Quarterly Result Update)

May 29, 2019 | Updated on May 29, 2019

For the quarter ended March 2019, PFIZER has posted a net profit of Rs 1 bn (up 4.7% YoY). Sales on the other hand came in at Rs 5 bn (up 3.0% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (3QFY19); Net Profit Up 51.2% (Quarterly Result Update)

Jan 25, 2019 | Updated on Jan 25, 2019

For the quarter ended December 2018, PFIZER has posted a net profit of Rs 1 bn (up 51.2% YoY). Sales on the other hand came in at Rs 5 bn (up 12.5% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER 2017-18 Annual Report Analysis (Annual Result Update)

Jan 1, 2019 | Updated on Jan 1, 2019

Here's an analysis of the annual report of PFIZER for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PFIZER. Also includes updates on the valuation of PFIZER.

PFIZER Announces Quarterly Results (2QFY19); Net Profit Down 13.8% (Quarterly Result Update)

Nov 15, 2018 | Updated on Nov 15, 2018

For the quarter ended September 2018, PFIZER has posted a net profit of Rs 958 m (down 13.8% YoY). Sales on the other hand came in at Rs 5 bn (down 9.0% YoY). Read on for a complete analysis of PFIZER's quarterly results.

More Views on News

Most Popular

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

A Rare Opportunity to Buy the Top 5 Stocks in the Market(The 5 Minute Wrapup)

Sep 16, 2019

The stock market today is throwing up a great opportunity to pile on quality stocks.

This Company Will Do Well Despite the Slowdown(The 5 Minute Wrapup)

Sep 11, 2019

How financial inclusion provides a big runway for this stock recommendation.

The 5 Best Trading Opportunities I've Spotted(Profit Hunter)

Sep 13, 2019

These 10 auto stocks should be in your watchlist for the next 32 months. Paste them on your workstation NOW.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Sep 19, 2019 (Close)

TRACK PFIZER

COMPARE PFIZER WITH

MARKET STATS